Belvedere Trading
NAUT icon

Belvedere Trading’s Nautilus Biotechnolgy NAUT Stock Holding History

Belvedere Trading’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,985
Closed -$24.9K – 1024
2023
Q1 		$24.9K Buy
+8,985
New +$18.8K ﹤0.01% 681
2021
Q4 		– Sell
-52,539
Closed -$292K – 558
2021
Q3 		$292K Buy
+52,539
New +$419K 0.01% 189

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $473M AUM 49.24% 1-Year Est. Return
AEPLI
AH Equity Partners LSV II Menlo Park, California $95.6M AUM 8.86% 1-Year Est. Return

Belvedere Trading's NAUT Position: Q2 2023 in Review

Belvedere Trading sold out of Nautilus Biotechnolgy (NAUT) in Q2 2023, closing a stake of 8,985 shares — an estimated $24.9K sold.

Belvedere Trading first reported a position in NAUT in Q3 2021 and held it in 2 quarters. The position peaked at $292K in Q3 2021. 75 funds tracked by Wall St. Rank hold NAUT as of Q2 2023.

  • Belvedere Trading reported no remaining Nautilus Biotechnolgy position as of Q2 2023 after selling out during the quarter.
  • Belvedere Trading sold 8,985 Nautilus Biotechnolgy shares in Q2 2023, an estimated $24.9K.
  • Belvedere Trading first reported a position in Nautilus Biotechnolgy in Q3 2021 and held it in 2 quarters.
  • Belvedere Trading's Nautilus Biotechnolgy position peaked at $292K in Q3 2021.
  • 75 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2023.

Based on Belvedere Trading's 13F filing for Q2 2023, filed 8 Aug 2023.